Wed, 30th Jun 2010 07:45 LONDON, June 30 (Reuters) - Futura Medical PLC:
* Signed a development agreement with gla
xosmithkline (gsk) for development of tpr100
* Under the agreement gsk will fully fund, be responsible for all clinical and
regulatory development
((London Equities Newsroom; +44 20 7542 7717))
(For more news, please click here)
COPYRIGHT
Copyright Thomson Reuters 2010. All rights reserved.
The copying, republication or redistribution of Reuters News Content, including by framing or similar means, is expressly prohibited without the prior written consent of Thomson Reuters.